MSH6 and Lynch syndrome: The development of this MS-stable and TMB-high tumor in this patient may be attributed to a germline mutation in MSH6. In Lynch syndrome (LS), germline mutations in MMR genes (MLH1, MSH2, MSH6, PMS2, and EPCAM) predispose individuals to various malignancies, including colorectal and endometrial cancers.